Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
GBIO
GBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GBIO News
XOMA Royalty Completes Acquisition of Generation Bio
6d ago
Newsfilter
Halper Sadeh Investigates Shareholder Rights Violations at Diamond Hill, Generation Bio, and Contango
Jan 23 2026
PRnewswire
Halper Sadeh Investigates Contango ORE Merger with Dolly Varden Silver Corporation
Jan 13 2026
PRnewswire
ScinoPharm Secures FDA Approval for Glatiramer Acetate Injection in Multiple Sclerosis
Jan 09 2026
NASDAQ.COM
Quipt Home Medical to Sell for $3.65 per Share to Kingswood and Forager
Dec 16 2025
PRnewswire
XOMA Enters Agreement to Purchase Generation Bio, Enhancing Royalty Holdings
Dec 16 2025
NASDAQ.COM
Generation Bio Investigated for Fiduciary Breaches in XOMA Deal, Shareholders to Receive $4.29 per Share
Dec 16 2025
PRnewswire
Halper Sadeh Investigates Generation Bio's $4.29 Sale to XOMA for Shareholder Fairness
Dec 16 2025
Businesswire
XOMA Royalty Acquires Generation Bio at $4.2913 per Share
Dec 15 2025
Globenewswire
XOMA Royalty Acquires Generation Bio at $4.2913 per Share
Dec 15 2025
Newsfilter
XOMA Royalty Set to Purchase Generation Bio
Dec 15 2025
SeekingAlpha
Compass Pathways Names Dr. Jeffrey Jonas to Its Board of Directors
Oct 29 2025
Newsfilter
Needham Reiterates Buy on Generation Bio, Maintains $15 Price Target
Aug 13 2025
Benzinga
Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Aug 13 2025
Benzinga
Generation Bio soars as it explores strategic alternatives
Aug 13 2025
SeekingAlpha
Generation Bio Posts 81% Q2 Revenue Drop
Aug 13 2025
NASDAQ.COM
Show More News
